|
|
Legal status
Patent not validated
| (51) | INT.CL. | C07D 213/65 | |
| A61K 31/44 | |||
| A61P 7/00 | |||
| C07D 213/81 |
| (11) | Number of the document | 3549932 |
| (13) | Kind of document | T |
| (96) | European patent application number | 17881314.3 |
| Date of filing the European patent application | 2017-12-13 | |
| (97) | Date of publication of the European application | 2019-10-09 |
| (45) | Date of publication and mention of the grant of the patent | 2020-09-30 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/CN2017/115909 |
| Date | 2017-12-13 |
| (87) | Number | WO 2018/108101 |
| Date | 2018-06-21 |
| (30) | Number | Date | Country code |
| 201611148362 | 2016-12-13 | CN |
| (72) |
CHEN, Minhua, CN
ZHANG, Yanfeng, CN
ZOU, Po, CN
WANG, Jinqiu, CN
ZHANG, Xiaoyu, CN
|
| (73) |
Crystal Pharmaceutical (Suzhou) Co., Ltd.,
B4-301 Biobay 218 Xinghu Street Suzhou Industrial Park, Suzhou, Jiangsu 215123,
CN
|
| (54) | NOVEL CRYSTALLINE FORMS OF {[5-(3-CHLOROPHENYL)-3-HYDROXYPYRIDINE-2-CARBONYL]AMINO}ACETIC ACID AND PROCESSES FOR PREPARATION THEREOF |
| NOVEL CRYSTALLINE FORMS OF {[5-(3-CHLOROPHENYL)-3-HYDROXYPYRIDINE-2-CARBONYL]AMINO}ACETIC ACID AND PROCESSES FOR PREPARATION THEREOF |